Armistice Capital exercises 85,000 pre-funded warrants in HCW Biologics

HCW Biologics Inc.

On June 12, 2025, Armistice exercised pre-funded warrants for 85,000 shares of HCWB common stock at $0.0001 per share.
This exercise leaves Armistice holding pre-funded warrants exercisable for 54,000 additional shares.
Prior exercises: 177,140 shares on May 15, 126,000 on May 22, and 71,000 on May 29, 2025.
The warrants were issued under a Securities Purchase Agreement dated May 13, 2025.

item 8.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.